325 related articles for article (PubMed ID: 21316753)
21. Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.
Saxby BK; Harrington F; Wesnes KA; McKeith IG; Ford GA
Neurology; 2008 May; 70(19 Pt 2):1858-66. PubMed ID: 18458219
[TBL] [Abstract][Full Text] [Related]
22. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
[TBL] [Abstract][Full Text] [Related]
23. Valsartan treatment of hypertension--does VALUE add value?
Lindholm LH
Lancet; 2004 Jun; 363(9426):2010-1. PubMed ID: 15207946
[No Abstract] [Full Text] [Related]
24. Clinical trial rigging: again!
Prescrire Int; 2014 Apr; 23(148):110. PubMed ID: 24860906
[No Abstract] [Full Text] [Related]
25. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
Chrysant SG
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
[TBL] [Abstract][Full Text] [Related]
26. [E-COST].
Kanno Y; Suzuki H
Nihon Rinsho; 2006 Aug; 64 Suppl 6():480-5. PubMed ID: 16981581
[No Abstract] [Full Text] [Related]
27. [Despite drug treatment, ever second hypertensive patient with morning blood pressure too high].
MMW Fortschr Med; 2004 Aug; 146(33-34):52. PubMed ID: 15526635
[No Abstract] [Full Text] [Related]
28. A third amlodipine/ARB combination (Twynsta) for hypertension.
Med Lett Drugs Ther; 2010 Jan; 52(1329):2-3. PubMed ID: 20208469
[No Abstract] [Full Text] [Related]
29. Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study.
Pais P; Jung H; Dans A; Zhu J; Liu L; Kamath D; Bosch J; Lonn E; Yusuf S
Eur J Prev Cardiol; 2019 May; 26(7):681-697. PubMed ID: 30537846
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients.
Scholze J; Schaefer A; Kreutz R
Expert Opin Drug Saf; 2011 Mar; 10(2):185-96. PubMed ID: 21254872
[TBL] [Abstract][Full Text] [Related]
31. [Scope].
Kim S
Nihon Rinsho; 2004 Mar; 62 Suppl 3():644-7. PubMed ID: 15171449
[No Abstract] [Full Text] [Related]
32. Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan.
Volpe M
Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):1061-72. PubMed ID: 23030295
[TBL] [Abstract][Full Text] [Related]
33. [Risk oriented therapy of hypertension. Lowering blood pressure and risk].
MMW Fortschr Med; 2007 Nov; 149(46):53. PubMed ID: 18069196
[No Abstract] [Full Text] [Related]
34. Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST).
Hornslien AG; Sandset EC; Igland J; Terént A; Boysen G; Bath PM; Murray GD; Berge E
Int J Stroke; 2015 Aug; 10(6):830-5. PubMed ID: 25808741
[TBL] [Abstract][Full Text] [Related]
35. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
London G; Schmieder R; Calvo C; Asmar R
Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
[TBL] [Abstract][Full Text] [Related]
36. [CASE-J].
Fukui T
Nihon Rinsho; 2006 Aug; 64 Suppl 6():449-53. PubMed ID: 16981578
[No Abstract] [Full Text] [Related]
37. From TROPHY with pride.
Julius S; Schork A; Egan BM
Am J Hypertens; 2007 Mar; 20(3):342-3; author reply 343-5. PubMed ID: 17324750
[No Abstract] [Full Text] [Related]
38. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
Weisser B; Gerwe M; Braun M; Funken C
Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
[TBL] [Abstract][Full Text] [Related]
39. ARB candesartan and CCB amlodipine in hypertensive patients: the CASE-J trial.
Ogihara T; Fujimoto A; Nakao K; Saruta T;
Expert Rev Cardiovasc Ther; 2008 Oct; 6(9):1195-201. PubMed ID: 18939907
[TBL] [Abstract][Full Text] [Related]
40. [Not just blood pressure counts. How well are hypertensive patients controlled?].
MMW Fortschr Med; 2003 Sep; 145(38):64. PubMed ID: 14603692
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
